Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

US House Appropriators Keep A Bullseye On FDA’s CBD Regulation Development

Jul 07 2020

• By Malcolm Spicer

US map-cannibis-plants

Have you checked out HBW podcast?

New episodes every Thursday.

Related Content

FDA Budget Request Includes $5M For CBD Regulation With Pathway Unclear

Feb 12 2020

Confidentiality For Proprietary Information Drives FDA Plan To Generate More CBD Safety Data

Mar 06 2020

FDA Action Items For CBD Policy? The List Is Short Due To 'Critical' Data Gaps

Jan 20 2020

$2m For CBD Policy In FDA Budget, But No Directive On Setting Safe Level

Dec 19 2019

Additional Topics

United States US States Cannabidiol CBD Legislation FDA Dietary Supplements Advertising, Marketing & Sales Commercial Compliance Enforcement Ingredients Manufacturing Policy Regulation Consumer

More from Cannabis/CBD

More from Ingredients & Safety

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window